Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer

Biochimie

Volumn 121, Issue , 2016, Pages 298-311

  Bhat, Samatha ^a   Kabekkodu, Shama Prasada ^a   Noronha, Ashish ^a   Satyamoorthy, Kapaettu ^a  

^a MANIPAL SCHOOL OF LIFE SCIENCES   (India)

Author keywords

Biomarkers; Cervical cancer; Diagnosis; DNA methylation; Epigenetic therapy; Epigenetics; Prognosis

Indexed keywords

BETA CATENIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN A1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FANCONI ANEMIA GROUP F PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR RUNX3; TUMOR MARKER; VON HIPPEL LINDAU PROTEIN;

APOPTOSIS; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER SCREENING; CELL ADHESION; CELL CYCLE; CELL CYCLE REGULATION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DNA METHYLATION; DNA REPAIR; EARLY DIAGNOSIS; EPIGENETICS; EXON; GENE CONTROL; HUMAN; METASTASIS; MOLECULARLY TARGETED THERAPY; PROMOTER REGION; REGULATOR GENE; REVIEW; UTERINE CERVIX CANCER; VIRUS GENOME; WART VIRUS; WNT SIGNALING PATHWAY; FEMALE; GENETICS; PAPILLOMAVIRIDAE; PATHOLOGY; PHYSIOLOGY; UTERINE CERVICAL NEOPLASMS;

DNA METHYLATION; FEMALE; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 84953449456     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.12.018     Document Type: Review

References (226)

1. M. Panjkovic, and T. Ivkovic-Kapicl Etiology and pathogenesis of precancerous lesions and invasive cervical carcinoma Med. Pregl. 61 2008 364 368
2. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J. Natl. Cancer Inst. 92 2000 690 698
3. E.L. Franco, E. Duarte-Franco, and A. Ferenczy Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection CMAJ 164 2001 1017 1025
4. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N. Engl. J. Med. 338 1998 423 428
5. H.C. Lai, Y.W. Lin, T.H. Huang, P. Yan, R.L. Huang, H.C. Wang, J. Liu, M.W. Chan, T.Y. Chu, C.A. Sun, C.C. Chang, and M.H. Yu Identification of novel DNA methylation markers in cervical cancer Int. J. Cancer 123 2008 161 167
6. A. Hermann, R. Goyal, and A. Jeltsch The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites J. Biol. Chem. 279 2004 48350 48359
7. T. Witte, C. Plass, and C. Gerhauser Pan-cancer patterns of DNA methylation Genome Med. 6 2014 66
8. G. Auclair, and M. Weber Mechanisms of DNA methylation and demethylation in mammals Biochimie 94 2012 2202 2211
9. A. Razin, and A.D. Riggs DNA methylation and gene function Science 210 1980 604 610
10. A. Kozlenkov, P. Roussos, A. Timashpolsky, M. Barbu, S. Rudchenko, M. Bibikova, B. Klotzle, W. Byne, R. Lyddon, A.F. Di Narzo, Y.L. Hurd, E.V. Koonin, and S. Dracheva Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites Nucleic Acids Res. 42 2013 109 127
11. M.J. Ziller, F. Muller, J. Liao, Y. Zhang, H. Gu, C. Bock, P. Boyle, C.B. Epstein, B.E. Bernstein, T. Lengauer, A. Gnirke, and A. Meissner Genomic distribution and inter-sample variation of non-CpG methylation across human cell types PLoS Genet. 7 2011 e1002389
12. V.V. Ashapkin, L.I. Kutueva, and B.F. Vanyushin The gene for domains rearranged methyltransferase (DRM2) in Arabidopsis thaliana plants is methylated at both cytosine and adenine residues FEBS Lett. 532 2002 367 372
13. J.A. Pintor-Toro Adenine methylation in zein genes Biochem. Biophys. Res. Commun. 147 1987 1082 1087
14. K. Jabbari, and G. Bernardi Cytosine methylation and CpG, TpG (CpA) and TpA frequencies Gene 333 2004 143 149
15. M. Gardiner-Garden, and M. Frommer CpG islands in vertebrate genomes J. Mol. Biol. 196 1987 261 282
16. D. Takai, and P.A. Jones Comprehensive analysis of CpG islands in human chromosomes 21 and 22 Proc. Natl. Acad. Sci. U. S. A. 99 2002 3740 3745
17. F. Larsen, G. Gundersen, R. Lopez, and H. Prydz CpG islands as gene markers in the human genome Genomics 13 1992 1095 1107
18. Y.A. Medvedeva, M.V. Fridman, N.J. Oparina, D.B. Malko, E.O. Ermakova, I.V. Kulakovskiy, A. Heinzel, and V.J. Makeev Intergenic, gene terminal, and intragenic CpG islands in the human genome BMC Genomics 11 2010 48
19. K.D. Robertson DNA methylation and human disease Nat. Rev. Genet. 6 2005 597 610
20. A.P. Feinberg, and B. Vogelstein Hypomethylation distinguishes genes of some human cancers from their normal counterparts Nature 301 1983 89 92
21. R.Z. Chen, U. Pettersson, C. Beard, L. Jackson-Grusby, and R. Jaenisch DNA hypomethylation leads to elevated mutation rates Nature 395 1998 89 93
22. A. Duenas-Gonzalez, M. Lizano, M. Candelaria, L. Cetina, C. Arce, and E. Cervera Epigenetics of cervical cancer. An overview and therapeutic perspectives Mol. Cancer 4 2005 38
23. F.X. Bosch, A.N. Burchell, M. Schiffman, A.R. Giuliano, S. de Sanjose, L. Bruni, G. Tortolero-Luna, S.K. Kjaer, and N. Munoz Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia Vaccine 26 Suppl. 10 2008 K1 K16
24. J.R. Daling, M.M. Madeleine, L.G. Johnson, S.M. Schwartz, K.A. Shera, M.A. Wurscher, J.J. Carter, P.L. Porter, D.A. Galloway, and J.K. McDougall Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer Cancer 101 2004 270 280
25. J.R. Daling, M.M. Madeleine, L.G. Johnson, S.M. Schwartz, K.A. Shera, M.A. Wurscher, J.J. Carter, P.L. Porter, D.A. Galloway, J.K. McDougall, and J.N. Krieger Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease Int. J. Cancer 116 2005 606 616
26. J.R. Daling, M.M. Madeleine, S.M. Schwartz, K.A. Shera, J.J. Carter, B. McKnight, P.L. Porter, D.A. Galloway, J.K. McDougall, and H. Tamimi A population-based study of squamous cell vaginal cancer: HPV and cofactors Gynecol. Oncol. 84 2002 263 270
27. G. D'Souza, N.D. Gross, S.I. Pai, R. Haddad, K.S. Anderson, S. Rajan, J. Gerber, M.L. Gillison, and M.R. Posner Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners J. Clin. Oncol. 32 2014 2408 2415
28. M.M. Madeleine, J.R. Daling, J.J. Carter, G.C. Wipf, S.M. Schwartz, B. McKnight, R.J. Kurman, A.M. Beckmann, M.E. Hagensee, and D.A. Galloway Cofactors with human papillomavirus in a population-based study of vulvar cancer J. Natl. Cancer Inst. 89 1997 1516 1523
29. M. Srodon, M.H. Stoler, G.B. Baber, and R.J. Kurman The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN) Am. J. Surg. Pathol. 30 2006 1513 1518
30. E.M. Burd Human papillomavirus and cervical cancer Clin. Microbiol. Rev. 16 2003 1 17
31. M. Conrad, D. Goldstein, T. Andresson, and R. Schlegel The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors Virology 200 1994 796 800
32. M.S. Longworth, and L.A. Laimins Pathogenesis of human papillomaviruses in differentiating epithelia Microbiol. Mol. Biol. Rev. 68 2004 362 372
33. E.K. Yim, and J.S. Park The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis Cancer Res. Treat. 37 2005 319 324
34. P. Hawley-Nelson, K.H. Vousden, N.L. Hubbert, D.R. Lowy, and J.T. Schiller HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes EMBO J. 8 1989 3905 3910
35. D.V. Heck, C.L. Yee, P.M. Howley, and K. Munger Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses Proc. Natl. Acad. Sci. U. S. A. 89 1992 4442 4446
36. M. Scheffner, J.M. Huibregtse, R.D. Vierstra, and P.M. Howley The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75 1993 495 505
37. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
38. S. Duensing, and K. Munger Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability Oncogene 21 2002 6241 6248
39. Y.E. Chang, and L.A. Laimins Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31 J. Virol. 74 2000 4174 4182
40. C.A. Moody, and L.A. Laimins Human papillomavirus oncoproteins: pathways to transformation Nat. Rev. Cancer 10 2010 550 560
41. M. Nees, J.M. Geoghegan, T. Hyman, S. Frank, L. Miller, and C.D. Woodworth Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes J. Virol. 75 2001 4283 4296
42. M. Tommasino, and L. Crawford Human papillomavirus E6 and E7: proteins which deregulate the cell cycle Bioessays 17 1995 509 518
43. E. Poreba, J.K. Broniarczyk, and A. Gozdzicka-Jozefiak Epigenetic mechanisms in virus-induced tumorigenesis Clin. Epigenetics 2 2012 233 247
44. I. Martinez, A.S. Gardiner, K.F. Board, F.A. Monzon, R.P. Edwards, and S.A. Khan Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells Oncogene 27 2008 2575 2582
45. X. Wang, H.K. Wang, J.P. McCoy, N.S. Banerjee, J.S. Rader, T.R. Broker, C. Meyers, L.T. Chow, and Z.M. Zheng Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6 RNA 15 2009 637 647
46. D. Mazumder Indra, R.K. Singh, S. Mitra, S. Dutta, C. Chakraborty, P.S. Basu, R.K. Mondal, S. Roychoudhury, and C.K. Panda Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression Gynecol. Oncol. 123 2011 597 604
47. S. Tang, M. Tao, J.P. McCoy Jr., and Z.M. Zheng The E7 oncoprotein is translated from spliced E6∗I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation J. Virol. 80 2006 4249 4263
48. D.C. Ding, M.H. Chiang, H.C. Lai, C.A. Hsiung, C.Y. Hsieh, and T.Y. Chu Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia, European journal of obstetrics Gynecol. Reprod. Biol. 147 2009 215 220
49. D. Hong, F. Ye, W. Lu, Y. Hu, X. Wan, Y. Chen, and X. Xie Methylation status of the long control region of HPV 16 in clinical cervical specimens Mol. Med. Rep. 1 2008 555 560
50. T. Turan, M. Kalantari, I.E. Calleja-Macias, H.A. Cubie, K. Cuschieri, L.L. Villa, H. Skomedal, H.A. Barrera-Saldana, and H.U. Bernard Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 349 2006 175 183
51. E. de la Cruz-Hernandez, E. Perez-Cardenas, A. Contreras-Paredes, D. Cantu, A. Mohar, M. Lizano, and A. Duenas-Gonzalez The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study Virol. J. 4 2007 18
52. L. Mirabello, M. Schiffman, A. Ghosh, A.C. Rodriguez, N. Vasiljevic, N. Wentzensen, R. Herrero, A. Hildesheim, S. Wacholder, D. Scibior-Bentkowska, R.D. Burk, and A.T. Lorincz Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia Int. J. Cancer 132 2012 1412 1422
53. H.J. Yang Aberrant DNA methylation in cervical carcinogenesis Chin. J. Cancer 32 2012 42 48
54. N. Oka, M. Kajita, R. Nishimura, C. Ohbayashi, and T. Sudo L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc. 23 2013 235 243
55. I. Murakami, T. Fujii, K. Dan, M. Saito, A. Ohno, T. Iwata, and D. Aoki Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia J. Clin. Virol. 58 2013 149 154
56. L. Marongiu, A. Godi, J.V. Parry, and S. Beddows Human Papillomavirus 16, 18, 31 and 45 viral load, integration and methylation status stratified by cervical disease stage BMC Cancer 14 2014 384
57. S. Hu, J. Wan, Y. Su, Q. Song, Y. Zeng, H.N. Nguyen, J. Shin, E. Cox, H.S. Rho, C. Woodard, S. Xia, S. Liu, H. Lyu, G.L. Ming, H. Wade, H. Song, J. Qian, and H. Zhu DNA methylation presents distinct binding sites for human transcription factors Elife 2 2013 e00726
58. M.R. Campanero, M.I. Armstrong, and E.K. Flemington CpG methylation as a mechanism for the regulation of E2F activity Proc. Natl. Acad. Sci. U. S. A. 97 2000 6481 6486
59. M. Comb, and H.M. Goodman CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 Nucleic Acids Res. 18 1990 3975 3982
60. J. Kim, A. Kollhoff, A. Bergmann, and L. Stubbs Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3 Hum. Mol. Genet. 12 2003 233 245
61. A. Kirillov, B. Kistler, R. Mostoslavsky, H. Cedar, T. Wirth, and Y. Bergman A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus Nat. Genet. 13 1996 435 441
62. G.C. Prendergast, D. Lawe, and E.B. Ziff Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation Cell 65 1991 395 407
63. F. Weih, D. Nitsch, A. Reik, G. Schutz, and P.B. Becker Analysis of CpG methylation and genomic footprinting at the tyrosine aminotransferase gene: DNA methylation alone is not sufficient to prevent protein binding in vivo EMBO J. 10 1991 2559 2567
64. M. Petrovich, and D.B. Veprintsev Effects of CpG methylation on recognition of DNA by the tumour suppressor p53 J. Mol. Biol. 386 2009 72 80
65. F. Radtke, M. Hug, O. Georgiev, K. Matsuo, and W. Schaffner Differential sensitivity of zinc finger transcription factors MTF-1, Sp1 and Krox-20 to CpG methylation of their binding sites Biol. Chem. Hoppe Seyler 377 1996 47 56
66. G. Perini, D. Diolaiti, A. Porro, and G. Della Valle In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation Proc. Natl. Acad. Sci. U. S. A. 102 2005 12117 12122
67. C. Marchal, and B. Miotto Emerging concept in DNA methylation: role of transcription factors in shaping DNA methylation patterns J. Cell Physiol. 230 2014 743 751
68. C. Gazin, N. Wajapeyee, S. Gobeil, C.M. Virbasius, and M.R. Green An elaborate pathway required for Ras-mediated epigenetic silencing Nature 449 2007 1073 1077
69. R.W. Serra, M. Fang, S.M. Park, L. Hutchinson, and M.R. Green A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype Elife 3 2014 e02313
70. G. Thillainadesan, J.M. Chitilian, M. Isovic, J.N. Ablack, J.S. Mymryk, M. Tini, and J. Torchia TGF-beta-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex Mol. Cell 46 2012 636 649
71. R.K. Palakurthy, N. Wajapeyee, M.K. Santra, C. Gazin, L. Lin, S. Gobeil, and M.R. Green Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression Mol. Cell 36 2009 219 230
72. Y.Y. Kan, Y.L. Liou, H.J. Wang, C.Y. Chen, L.C. Sung, C.F. Chang, and C.I. Liao PAX1 methylation as a potential biomarker for cervical cancer screening Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc. 24 2014 928 934
73. A.K. Jha, M. Nikbakht, V. Jain, A. Sehgal, N. Capalash, and J. Kaur Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population Mol. Biol. Rep. 39 2012 9145 9157
74. S. Guenin, M. Mouallif, R. Deplus, X. Lampe, N. Krusy, E. Calonne, K. Delbecque, F. Kridelka, F. Fuks, M.M. Ennaji, and P. Delvenne Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis PLoS One 7 2012 e42704
75. N. Missaoui, S. Hmissa, A. Trabelsi, C. Traore, M. Mokni, R. Dante, and L. Frappart Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix Pathol. Res. Pract. 207 2010 37 42
76. M. Beger, K. Butz, C. Denk, T. Williams, H.C. Hurst, and F. Hoppe-Seyler Expression pattern of AP-2 transcription factors in cervical cancer cells and analysis of their influence on human papillomavirus oncogene transcription J. Mol. Med. 79 2001 314 320
77. R.K. Lin, C.Y. Wu, J.W. Chang, L.J. Juan, H.S. Hsu, C.Y. Chen, Y.Y. Lu, Y.A. Tang, Y.C. Yang, P.C. Yang, and Y.C. Wang Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer Cancer Res. 70 2010 5807 5817
78. F. Wang, Y. Li, J. Zhou, J. Xu, C. Peng, F. Ye, Y. Shen, W. Lu, X. Wan, and X. Xie miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1 Am. J. Pathol. 179 2011 2580 2588
79. G. Howard, R. Eiges, F. Gaudet, R. Jaenisch, and A. Eden Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice Oncogene 27 2008 404 408
80. L. Sigalotti, E. Fratta, E. Bidoli, A. Covre, G. Parisi, F. Colizzi, S. Coral, S. Massarut, J.M. Kirkwood, and M. Maio Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients J. Transl. Med. 9 2011 78
81. Y.I. Kim, A. Giuliano, K.D. Hatch, A. Schneider, M.A. Nour, G.E. Dallal, J. Selhub, and J.B. Mason Global DNA hypomethylation increases progressively in cervical dysplasia and carcinoma Cancer 74 1994 893 899
82. S. Douc-Rasy, M. Barrois, S. Fogel, J.C. Ahomadegbe, D. Stehelin, J. Coll, and G. Riou High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19 Oncogene 12 1996 423 430
83. B.M. Fowler, A.R. Giuliano, C. Piyathilake, M. Nour, and K. Hatch Hypomethylation in cervical tissue: is there a correlation with folate status? Cancer Epidemiol. Biomarkers Prev. 7 1998 901 906
84. V. Badal, L.S. Chuang, E.H. Tan, S. Badal, L.L. Villa, C.M. Wheeler, B.F. Li, and H.U. Bernard CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression J. Virol. 77 2003 6227 6234
85. D.S. Gerhard, L.T. Nguyen, Z.Y. Zhang, I.B. Borecki, B.I. Coleman, and J.S. Rader A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer Gynecol. Oncol. 90 2003 560 565
86. J.W. Sull, S.H. Jee, S. Yi, J.E. Lee, J.S. Park, S. Kim, and H. Ohrr The effect of methylenetetrahydrofolate reductase polymorphism C677T on cervical cancer in Korean women Gynecol. Oncol. 95 2004 557 563
87. C. Banzai, K. Nishino, J. Quan, K. Yoshihara, M. Sekine, T. Yahata, and K. Tanaka Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma Int. J. Clin. Oncol. 19 2013 127 132
88. T.S. Lee, J.W. Kim, G.H. Kang, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee DNA hypomethylation of CAGE promotors in squamous cell carcinoma of uterine cervix Ann. N. Y. Acad. Sci. 1091 2006 218 224
89. J. Samuelsson, S. Alonso, T. Ruiz-Larroya, T.H. Cheung, Y.F. Wong, and M. Perucho Frequent somatic demethylation of RAPGEF1/C3G intronic sequences in gastrointestinal and gynecological cancer Int. J. Oncol. 38 2011 1575 1577
90. S. Shuangshoti, N. Hourpai, U. Pumsuk, and A. Mutirangura Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix Asian Pac. J. Cancer Prev. 8 2007 307 309
91. N. Missaoui, S. Hmissa, R. Dante, and L. Frappart Global DNA methylation in precancerous and cancerous lesions of the uterine cervix Asian Pac. J. Cancer Prev. 11 2011 1741 1744
92. J. Jiang, L.J. Zhao, C. Zhao, G. Zhang, Y. Zhao, J.R. Li, X.P. Li, and L.H. Wei Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells Gynecol. Oncol. 124 2011 534 541
93. J.F. Costello, M.C. Fruhwald, D.J. Smiraglia, L.J. Rush, G.P. Robertson, X. Gao, F.A. Wright, J.D. Feramisco, P. Peltomaki, J.C. Lang, D.E. Schuller, L. Yu, C.D. Bloomfield, M.A. Caligiuri, A. Yates, R. Nishikawa, H. Su Huang, N.J. Petrelli, X. Zhang, M.S. O'Dorisio, W.A. Held, W.K. Cavenee, and C. Plass Aberrant CpG-island methylation has non-random and tumour-type-specific patterns Nat. Genet. 24 2000 132 138
94. A. How Kit, H.M. Nielsen, and J. Tost DNA methylation based biomarkers: practical considerations and applications Biochimie 94 2012 2314 2337
95. P.A. Jones, and P.W. Laird Cancer epigenetics comes of age Nat. Genet. 21 1999 163 167
96. C.L. Doci, T.P. Mankame, A. Langerman, K.R. Ostler, R. Kanteti, T. Best, K. Onel, L.A. Godley, R. Salgia, and M.W. Lingen Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol. 31 2012 15 24
97. G. Lev Maor, A. Yearim, and G. Ast The alternative role of DNA methylation in splicing regulation Trends Genet. 31 2015 274 280
98. A.E. Kornienko, P.M. Guenzl, D.P. Barlow, and F.M. Pauler Gene regulation by the act of long non-coding RNA transcription BMC Biol. 11 2013 59
99. N. Shenker, and J.M. Flanagan Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research Br. J. Cancer 106 2012 248 253
100. L. Laurent, E. Wong, G. Li, T. Huynh, A. Tsirigos, C.T. Ong, H.M. Low, K.W. Kin Sung, I. Rigoutsos, J. Loring, and C.L. Wei Dynamic changes in the human methylome during differentiation Genome Res. 20 2010 320 331
101. S. Shukla, E. Kavak, M. Gregory, M. Imashimizu, B. Shutinoski, M. Kashlev, P. Oberdoerffer, R. Sandberg, and S. Oberdoerffer CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing Nature 479 2011 74 79
102. M. Singer, I. Kosti, L. Pachter, and Y. Mandel-Gutfreund A diverse epigenetic landscape at human exons with implication for expression Nucleic Acids Res. 43 2015 3498 3508
103. A.K. Maunakea, I. Chepelev, K. Cui, and K. Zhao Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition Cell Res. 23 2013 1256 1269
104. M.C. Lorincz, D.R. Dickerson, M. Schmitt, and M. Groudine Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells Nat. Struct. Mol. Biol. 11 2004 1068 1075
105. A.K. Maunakea, R.P. Nagarajan, M. Bilenky, T.J. Ballinger, C. D'Souza, S.D. Fouse, B.E. Johnson, C. Hong, C. Nielsen, Y. Zhao, G. Turecki, A. Delaney, R. Varhol, N. Thiessen, K. Shchors, V.M. Heine, D.H. Rowitch, X. Xing, C. Fiore, M. Schillebeeckx, S.J. Jones, D. Haussler, M.A. Marra, M. Hirst, T. Wang, and J.F. Costello Conserved role of intragenic DNA methylation in regulating alternative promoters Nature 466 2010 253 257
106. A.J. Wood, R. Schulz, K. Woodfine, K. Koltowska, C.V. Beechey, J. Peters, D. Bourc'his, and R.J. Oakey Regulation of alternative polyadenylation by genomic imprinting Genes Dev. 22 2008 1141 1146
107. F. Brenet, M. Moh, P. Funk, E. Feierstein, A.J. Viale, N.D. Socci, and J.M. Scandura DNA methylation of the first exon is tightly linked to transcriptional silencing PLoS One 6 2011 e14524
108. J. de Wilde, J.M. Kooter, R.M. Overmeer, D. Claassen-Kramer, C.J. Meijer, P.J. Snijders, and R.D. Steenbergen hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis BMC Cancer 10 2010 271
109. T. Ivanova, A. Petrenko, T. Gritsko, S. Vinokourova, E. Eshilev, V. Kobzeva, F. Kisseljov, and N. Kisseljova Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer BMC Cancer 2 2002 4
110. A.C. Vidal, N.M. Henry, S.K. Murphy, O. Oneko, M. Nye, J.A. Bartlett, F. Overcash, Z. Huang, F. Wang, P. Mlay, J. Obure, J. Smith, B. Vasquez, B. Swai, B. Hernandez, and C. Hoyo PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer Clin. Transl. Oncol. 16 2013 266 272
111. J.H. Wu, X.A. Liang, Y.M. Wu, F.S. Li, and Y.M. Dai Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay Oncol. Rep. 29 2012 125 132
112. A. Ashkenazi, and V.M. Dixit Apoptosis control by death and decoy receptors Curr. Opin. Cell Biol. 11 1999 255 260
113. N. Ozoren, and W.S. El-Deiry Cell surface Death Receptor signaling in normal and cancer cells Semin. Cancer Biol. 13 2003 135 147
114. S.S. Liu, R.C. Leung, K.Y. Chan, P.M. Chiu, A.N. Cheung, K.F. Tam, T.Y. Ng, L.C. Wong, and H.Y. Ngan p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy Clin. Cancer Res. 10 2004 3309 3316
115. L. Roz, M. Gramegna, H. Ishii, C.M. Croce, and G. Sozzi Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines Proc. Natl. Acad. Sci. U. S. A. 99 2002 3615 3620
116. S. Snellenberg, S.A. Cillessen, W. Van Criekinge, L. Bosch, C.J. Meijer, P.J. Snijders, and R.D. Steenbergen Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers Carcinogenesis 35 2014 2611 2618
117. Q. Wu, H. Shi, Z. Suo, and J.M. Nesland 5′-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas Ultrastruct. Pathol. 27 2003 417 422
118. H.J. Yang, V.W. Liu, Y. Wang, P.C. Tsang, and H.Y. Ngan Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data BMC Cancer 6 2006 212
119. J. Xiong, Y. Li, K. Huang, M. Lu, H. Shi, L. Ma, A. Luo, S. Yang, Z. Lu, J. Zhang, L. Yang, and S. Wang Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis PLoS One 9 2014 e107272
120. Y.T. Kim, and M. Zhao Aberrant cell cycle regulation in cervical carcinoma Yonsei Med. J. 46 2005 597 613
121. R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, U. Petry, G. Dallenbach-Hellweg, D. Schmidt, and M. von Knebel Doeberitz Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri Int. J. Cancer 92 2001 276 284
122. A.K. Jha, M. Nikbakht, V. Jain, N. Capalash, and J. Kaur p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients Oncol. Lett. 3 2012 1331 1335
123. H. zur Hausen Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types Curr. Top. Microbiol. Immunol. 186 1994 131 156
124. N. Kitkumthorn, P. Yanatatsanajit, S. Kiatpongsan, C. Phokaew, S. Triratanachat, P. Trivijitsilp, W. Termrungruanglert, D. Tresukosol, S. Niruthisard, and A. Mutirangura Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer BMC Cancer 6 2006 55
125. N. Yang, E.R. Nijhuis, H.H. Volders, J.J. Eijsink, A. Lendvai, B. Zhang, H. Hollema, E. Schuuring, G.B. Wisman, and A.G. van der Zee Gene promoter methylation patterns throughout the process of cervical carcinogenesis Cell Oncol. 32 2010 131 143
126. K.D. Ki, S.K. Lee, S.Y. Tong, J.M. Lee, D.H. Song, and S.G. Chi Role of 5′-CpG island hypermethylation of the FHIT gene in cervical carcinoma J. Gynecol. Oncol. 19 2008 117 122
127. S.P. Kabekkodu, S. Bhat, R. Radhakrishnan, A. Aithal, R. Mascarenhas, D. Pandey, L. Rai, P. Kushtagi, G.P. Mundyat, and K. Satyamoorthy DNA promoter methylation-dependent transcription of the double C2-like domain beta (DOC2B) gene regulates tumor growth in human cervical cancer J. Biol. Chem. 289 2014 10637 10649
128. K. Aoki, and M.M. Taketo Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene J. Cell Sci. 120 2007 3327 3335
129. S.M. Dong, H.S. Kim, S.H. Rha, and D. Sidransky Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix Clin. Cancer Res. 7 2001 1982 1986
130. Y. Song, and C. Zhang Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression Cancer Chemother. Pharmacol. 63 2009 605 613
131. M.T. Chung, H.K. Sytwu, M.D. Yan, Y.L. Shih, C.C. Chang, M.H. Yu, T.Y. Chu, H.C. Lai, and Y.W. Lin Promoter methylation of SFRPs gene family in cervical cancer Gynecol. Oncol. 112 2009 301 306
132. A.L. Delmas, B.M. Riggs, C.E. Pardo, L.M. Dyer, R.P. Darst, E.G. Izumchenko, M. Monroe, A. Hakam, M.P. Kladde, E.M. Siegel, and K.D. Brown WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix Carcinogenesis 32 2011 1625 1633
133. H.C. Lai, Y.C. Ou, T.C. Chen, H.J. Huang, Y.M. Cheng, C.H. Chen, T.Y. Chu, S.T. Hsu, C.B. Liu, Y.C. Hung, K.C. Wen, M.H. Yu, and K.L. Wang PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study Cancer Med. 3 2014 1062 1074
134. J. Lee, D.J. Jeong, J. Kim, S. Lee, J.H. Park, B. Chang, S.I. Jung, L. Yi, Y. Han, Y. Yang, K.I. Kim, J.S. Lim, I. Yang, S. Jeon, D.H. Bae, C.J. Kim, and M.S. Lee The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma Mol. Cancer 9 2010 109
135. J. Lee, Y.S. Yoon, and J.H. Chung Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines Gynecol. Oncol. 109 2008 270 274
136. M.M. Rizvi, M.S. Alam, A. Ali, S.J. Mehdi, S. Batra, and A.K. Mandal Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population J. Cancer Res. Clin. Oncol. 137 2011 1255 1262
137. G. Narayan, H. Arias-Pulido, S.V. Nandula, K. Basso, D.D. Sugirtharaj, H. Vargas, M. Mansukhani, J. Villella, L. Meyer, A. Schneider, L. Gissmann, M. Durst, B. Pothuri, and V.V. Murty Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer Cancer Res. 64 2004 2994 2997
138. H.J. Yang, V.W. Liu, Y. Wang, K.Y. Chan, P.C. Tsang, U.S. Khoo, A.N. Cheung, and H.Y. Ngan Detection of hypermethylated genes in tumor and plasma of cervical cancer patients Gynecol. Oncol. 93 2004 435 440
139. F.E. Henken, S.M. Wilting, R.M. Overmeer, J.G. van Rietschoten, A.O. Nygren, A. Errami, J.P. Schouten, C.J. Meijer, P.J. Snijders, and R.D. Steenbergen Sequential gene promoter methylation during HPV-induced cervical carcinogenesis Br. J. Cancer 97 2007 1457 1464
140. A.K. Virmani, C. Muller, A. Rathi, S. Zoechbauer-Mueller, M. Mathis, and A.F. Gazdar Aberrant methylation during cervical carcinogenesis Clin. Cancer Res. 7 2001 584 589
141. S. Chujan, N. Kitkumthorn, S. Siriangkul, and A. Mutirangura CCNA1 promoter methylation: a potential marker for grading Papanicolaou smear cervical squamous intraepithelial lesions Asian Pac. J. Cancer Prev. 15 2014 7971 7975
142. L.X. Bai, J.T. Wang, L. Ding, S.W. Jiang, H.J. Kang, C.F. Gao, X. Chen, C. Chen, and Q. Zhou Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization Asian Pac. J. Cancer Prev. 15 2014 9313 9317
143. H.Y. Cheng, X.W. Chen, L. Cheng, Y.D. Liu, and G. Lou DNA methylation and carcinogenesis of PRDM5 in cervical cancer J. Cancer Res. Clin. Oncol. 136 2010 1821 1825
144. L.M. De Strooper, M. van Zummeren, R.D. Steenbergen, M.C. Bleeker, A.T. Hesselink, G.B. Wisman, P.J. Snijders, D.A. Heideman, and C.J. Meijer CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer J. Clin. Pathol. 67 2014 1067 1071
145. K. Hagiwara, H. Ito, T. Murate, Y. Miyata, H. Ohashi, and H. Nagai PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation Genes Chromosom. Cancer 51 2012 1024 1036
146. J.H. Kim, Y.D. Choi, J.S. Lee, J.H. Lee, J.H. Nam, and C. Choi Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens Gynecol. Oncol. 116 2009 99 104
147. Z. Pan, W. Zheng, J. Zhang, R. Gao, D. Li, X. Guo, H. Han, F. Li, S. Qu, and R. Shao Down-regulation of the expression of CCAAT/enhancer binding protein alpha gene in cervical squamous cell carcinoma BMC Cancer 14 2014 417
148. L. Shao, Y. Cui, H. Li, Y. Liu, H. Zhao, Y. Wang, Y. Zhang, K.M. Ng, W. Han, D. Ma, and Q. Tao CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines Clin. Cancer Res. 13 2007 5756 5762
149. W.T. Yang, and P.S. Zheng Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis PLoS One 9 2014 e88827
150. Y. Wu, L. Meng, H. Wang, Q. Xu, S. Wang, S. Wu, L. Xi, Y. Zhao, J. Zhou, G. Xu, Y. Lu, and D. Ma Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis Oncol. Rep. 16 2006 625 629
151. S.B. Prasad, S.S. Yadav, M. Das, H.B. Govardhan, L.K. Pandey, S. Singh, S. Pradhan, and G. Narayan Down regulation of FOXO1 promotes cell proliferation in cervical cancer J. Cancer 5 2014 655 662
152. G. Narayan, H. Arias-Pulido, S. Koul, H. Vargas, F.F. Zhang, J. Villella, A. Schneider, M.B. Terry, M. Mansukhani, and V.V. Murty Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome Mol. Cancer 2 2003 24
153. B. Chang, J. Kim, D. Jeong, Y. Jeong, S. Jeon, S.I. Jung, Y. Yang, K.I. Kim, J.S. Lim, C. Kim, and M.S. Lee Klotho inhibits the capacity of cell migration and invasion in cervical cancer Oncol. Rep. 28 2012 1022 1028
154. I. Ramachandran, E. Thavathiru, S. Ramalingam, G. Natarajan, W.K. Mills, D.M. Benbrook, R. Zuna, S. Lightfoot, A. Reis, S. Anant, and L. Queimado Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo Oncogene 31 2011 2725 2737
155. T.T. Yao, S.M. Mo, L.Y. Liu, H.W. Lu, M.L. Huang, and Z.Q. Lin 5-Aza-2′-deoxycytidine may influence the proliferation and apoptosis of cervical cancer cells via demethylation in a dose- and time-dependent manner Genet. Mol. Res. 12 2013 312 318
156. C. Huisman, G.B. Wisman, H.G. Kazemier, M.A. van Vugt, A.G. van der Zee, E. Schuuring, and M.G. Rots Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors Mol. Oncol. 7 2013 669 679
157. C.L. Doci, T.P. Mankame, A. Langerman, K.R. Ostler, R. Kanteti, T. Best, K. Onel, L.A. Godley, R. Salgia, and M.W. Lingen Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol. 31 2011 15 24
158. W. Dong, L. Feng, Y. Xie, H. Zhang, and Y. Wu Hypermethylation-mediated reduction of LMX1A expression in gastric cancer Cancer Sci. 102 2010 361 366
159. E.J. Lee, M. Jo, S.B. Rho, K. Park, Y.N. Yoo, J. Park, M. Chae, W. Zhang, and J.H. Lee Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin Int. J. Cancer 124 2009 287 297
160. R.D. Steenbergen, D. Kramer, B.J. Braakhuis, P.L. Stern, R.H. Verheijen, C.J. Meijer, and P.J. Snijders TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia J. Natl. Cancer Inst. 96 2004 294 305
161. S.S. Yadav, S.B. Prasad, M. Das, S. Kumari, L.K. Pandey, S. Singh, S. Pradhan, and G. Narayan Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer Biomed. Res. Int. 2014 2014 581403
162. R.M. Overmeer, F.E. Henken, P.J. Snijders, D. Claassen-Kramer, J. Berkhof, T.J. Helmerhorst, D.A. Heideman, S.M. Wilting, Y. Murakami, A. Ito, C.J. Meijer, and R.D. Steenbergen Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC J. Pathol. 215 2008 388 397
163. C.L. Chen, S.S. Liu, S.M. Ip, L.C. Wong, T.Y. Ng, and H.Y. Ngan E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours Eur. J. Cancer 39 2003 517 523
164. D.H. Jeong, M.Y. Youm, Y.N. Kim, K.B. Lee, M.S. Sung, H.K. Yoon, and K.T. Kim Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics Int. J. Gynecol. Cancer Off. J. Int. Gynecol. Cancer Soc. 16 2006 1234 1240
165. Y.W. Lin, M.T. Chung, H.C. Lai, M. De Yan, Y.L. Shih, C.C. Chang, and M.H. Yu Methylation analysis of SFRP genes family in cervical adenocarcinoma J. Cancer Res. Clin. Oncol. 135 2009 1665 1674
166. M.T. Chung, H.C. Lai, H.K. Sytwu, M.D. Yan, Y.L. Shih, C.C. Chang, M.H. Yu, H.S. Liu, D.W. Chu, and Y.W. Lin SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway Gynecol. Oncol. 112 2009 646 653
167. C.Y. Liu, T.K. Chao, P.H. Su, H.Y. Lee, Y.L. Shih, H.Y. Su, T.Y. Chu, M.H. Yu, Y.W. Lin, and H.C. Lai Characterization of LMX-1A as a metastasis suppressor in cervical cancer J. Pathol. 219 2009 222 231
168. D. Guerrero-Setas, N. Perez-Janices, L. Blanco-Fernandez, A. Ojer, K. Cambra, M. Berdasco, M. Esteller, S. Maria-Ruiz, N. Torrea, and R. Guarch RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer Mod. Pathol. 26 2013 1111 1122
169. Q. Qi, Y. Ling, M. Zhu, L. Zhou, M. Wan, Y. Bao, and Y. Liu Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancer Biomed. Rep. 2 2014 653 658
170. J. Ying, H. Li, T.J. Seng, C. Langford, G. Srivastava, S.W. Tsao, T. Putti, P. Murray, A.T. Chan, and Q. Tao Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation Oncogene 25 2006 1070 1080
171. R.M. Overmeer, F.E. Henken, M. Bierkens, S.M. Wilting, I. Timmerman, C.J. Meijer, P.J. Snijders, and R.D. Steenbergen Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis J. Pathol. 219 2009 327 336
172. S. Jung, D. Jeong, J. Kim, L. Yi, K. Koo, J. Lee, C.J. Kim, C.H. Kim, S. An, Y. Yang, J.S. Lim, K.I. Kim, and M.S. Lee Epigenetic regulation of the potential tumor suppressor gene, hLHX6.1, in human cervical cancer Int. J. Oncol. 38 2011 859 869
173. M. Lando, C.S. Fjeldbo, S.M. Wilting, B. C Snoek, E.K. Aarnes, M.F. Forsberg, G.B. Kristensen, R.D. Steenbergen, and H. Lyng Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer Epigenetics 10 2015 970 980
174. C. Goessl, H. Krause, M. Muller, R. Heicappell, M. Schrader, J. Sachsinger, and K. Miller Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids Cancer Res. 60 2000 5941 5945
175. P.W. Laird The power and the promise of DNA methylation markers Nat. Rev. Cancer 3 2003 253 266
176. E.J. Lee, M. McClelland, Y. Wang, F. Long, S.H. Choi, and J.H. Lee Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix Oncol. Res. 18 2010 401 408
177. G.F. Sawaya, and D.A. Grimes New technologies in cervical cytology screening: a word of caution Obstet. Gynecol. 94 1999 307 310
178. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
179. J.J. Eijsink, A. Lendvai, V. Deregowski, H.G. Klip, G. Verpooten, L. Dehaspe, G.H. de Bock, H. Hollema, W. van Criekinge, E. Schuuring, A.G. van der Zee, and G.B. Wisman A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients Int. J. Cancer 130 2011 1861 1869
180. S. Jung, L. Yi, J. Kim, D. Jeong, T. Oh, C.H. Kim, C.J. Kim, J. Shin, S. An, and M.S. Lee The role of vimentin as a methylation biomarker for early diagnosis of cervical cancer Mol. Cells 31 2011 405 411
181. S. Mitra, D. Mazumder Indra, P.S. Basu, R.K. Mondal, A. Roy, S. Roychoudhury, and C.K. Panda Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance Mol. Carcinog. 51 2011 723 733
182. N. Yang, J.J. Eijsink, A. Lendvai, H.H. Volders, H. Klip, H.J. Buikema, B.M. van Hemel, E. Schuuring, A.G. van der Zee, and G.B. Wisman Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings Cancer Epidemiol. Biomarkers Prev. 18 2009 3000 3007
183. Z.J. Zhong, J.X. Yang, D.Y. Cao, Y. Sun, L.L. Sun, X.M. Cheng, J. Chen, J.H. Lang, and K. Shen Promoter methylation of DAPK1, RAR-beta and MGMT in exfoliated cervical cytology and its clinical application Zhonghua Fu Chan Ke Za Zhi 47 2012 196 200
184. M. Esteller, M. Sanchez-Cespedes, R. Rosell, D. Sidransky, S.B. Baylin, and J.G. Herman Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res. 59 1999 67 70
185. H. Usadel, J. Brabender, K.D. Danenberg, C. Jeronimo, S. Harden, J. Engles, P.V. Danenberg, S. Yang, and D. Sidransky Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res. 62 2002 371 375
186. Q. Feng, A. Balasubramanian, S.E. Hawes, P. Toure, P.S. Sow, A. Dem, B. Dembele, C.W. Critchlow, L. Xi, H. Lu, M.W. McIntosh, A.M. Young, and N.B. Kiviat Detection of hypermethylated genes in women with and without cervical neoplasia J. Natl. Cancer Inst. 97 2005 273 282
187. Z. Lin, M. Gao, X. Zhang, Y.S. Kim, E.S. Lee, H.K. Kim, and I. Kim The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions J. Cancer Res. Clin. Oncol. 131 2005 364 370
188. S. Kang, J.W. Kim, G.H. Kang, S. Lee, N.H. Park, Y.S. Song, S.Y. Park, S.B. Kang, and H.P. Lee Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma Int. J. Cancer 118 2006 2168 2171
189. H. Jo, S. Kang, J.W. Kim, G.H. Kang, N.H. Park, Y.S. Song, S.Y. Park, S.B. Kang, and H.P. Lee Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer J. Obstet. Gynaecol. Res. 33 2007 236 241
190. N. Shivapurkar, M.E. Sherman, V. Stastny, C. Echebiri, J.S. Rader, R. Nayar, T.A. Bonfiglio, A.F. Gazdar, and S.S. Wang Evaluation of candidate methylation markers to detect cervical neoplasia Gynecol. Oncol. 107 2007 549 553
191. N. Wentzensen, M.E. Sherman, M. Schiffman, and S.S. Wang Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science Gynecol. Oncol. 112 2009 293 299
192. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol. Oncol. 38 1990 352 357
193. V. Nicolet, L. Carignan, F. Bourdon, and O. Prosmanne MR imaging of cervical carcinoma: a practical staging approach Radiographics 20 2000 1539 1549
194. K. Banno, M. Yanokura, M. Kawaguchi, Y. Kuwabara, J. Akiyoshi, Y. Kobayashi, T. Iwata, A. Hirasawa, T. Fujii, N. Susumu, K. Tsukazaki, and D. Aoki Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes Int. J. Oncol. 31 2007 713 720
195. K. Masuda, K. Banno, M. Yanokura, K. Tsuji, Y. Kobayashi, I. Kisu, A. Ueki, W. Yamagami, H. Nomura, E. Tominaga, N. Susumu, and D. Aoki Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells Oncol. Rep. 28 2012 1146 1152
196. A. Widschwendter, H.M. Muller, H. Fiegl, L. Ivarsson, A. Wiedemair, E. Muller-Holzner, G. Goebel, C. Marth, and M. Widschwendter DNA methylation in serum and tumors of cervical cancer patients Clin. Cancer Res. 10 2004 565 571
197. A. Widschwendter, L. Ivarsson, A. Blassnig, H.M. Muller, H. Fiegl, A. Wiedemair, E. Muller-Holzner, G. Goebel, C. Marth, and M. Widschwendter CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients Int. J. Cancer 109 2004 163 166
198. W.S. Kang, S.B. Cho, J.S. Park, M.Y. Lee, S.C. Myung, W.Y. Kim, S.H. Lee, D.H. Kim, and E.J. Lee Clinico-epigenetic combination including quantitative methylation value of DKK3 augments survival prediction of the patient with cervical cancer J. Cancer Res. Clin. Oncol. 139 2012 97 106
199. Z.M. Lof-Ohlin, B. Sorbe, S. Wingren, and T.K. Nilsson Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients Int. J. Oncol. 39 2011 683 688
200. M.K. Lee, E.M. Jeong, J.H. Kim, S.B. Rho, and E.J. Lee Aberrant methylation of the VIM promoter in uterine cervical squamous cell carcinoma Oncology 86 2014 359 368
201. H.H. Chung, M.K. Kim, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer Gynecol. Oncol. 103 2006 1031 1037
202. M. Iida, K. Banno, M. Yanokura, K. Nakamura, M. Adachi, Y. Nogami, K. Umene, K. Masuda, I. Kisu, T. Iwata, K. Tanaka, and D. Aoki Candidate biomarkers for cervical cancer treatment: potential for clinical practice (Review) Mol. Clin. Oncol. 2 2014 647 655
203. S. Kummar, M. Raffeld, L. Juwara, Y. Horneffer, A. Strassberger, D. Allen, S.M. Steinberg, A. Rapisarda, S.D. Spencer, W.D. Figg, X. Chen, I.B. Turkbey, P. Choyke, A.J. Murgo, J.H. Doroshow, and G. Melillo Multihistology, target-driven pilot trial of oral topotecan as an inhibitor of hypoxia-inducible factor-1alpha in advanced solid tumors Clin. Cancer Res. 17 2011 5123 5131
204. A. Rapisarda, R.H. Shoemaker, and G. Melillo Targeting topoisomerase I to inhibit hypoxia inducible factor 1 Cell Cycle 3 2004 172 175
205. S. Paulikova, M. Chmelarova, J. Petera, V. Palicka, and A. Paulik Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients Folia Biol. (Praha) 59 2014 240 245
206. R. Brown, E. Curry, L. Magnani, C.S. Wilhelm-Benartzi, and J. Borley Poised epigenetic states and acquired drug resistance in cancer Nat. Rev. Cancer 14 2014 747 753
207. M. Candelaria, A. Garcia-Arias, L. Cetina, and A. Duenas-Gonzalez Radiosensitizers in cervical cancer. Cisplatin and beyond Radiat. Oncol. 1 2006 15
208. G. Egger, G. Liang, A. Aparicio, and P.A. Jones Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
209. S. Sharma, T.K. Kelly, and P.A. Jones Epigenetics in cancer Carcinogenesis 31 2009 27 36
210. P. Zambrano, B. Segura-Pacheco, E. Perez-Cardenas, L. Cetina, A. Revilla-Vazquez, L. Taja-Chayeb, A. Chavez-Blanco, E. Angeles, G. Cabrera, K. Sandoval, C. Trejo-Becerril, J. Chanona-Vilchis, and A. Duenas-Gonzalez A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes BMC Cancer 5 2005 44
211. T. Tanaka, T. Bai, S. Toujima, T. Utsunomiya, T. Matsuoka, A. Kobayashi, M. Yamamoto, N. Sasaki, Y. Tanizaki, H. Utsunomiya, J. Tanaka, and K. Yukawa Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells Oncol. Rep. 27 2012 1292 1298
212. P. Frost, J.L. Abbruzzese, B. Hunt, D. Lee, and M. Ellis Synergistic cytotoxicity using 2′-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells Cancer Res. 50 1990 4572 4577
213. S. Sood, and R. Srinivasan Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines Mol. Cell Biochem. 404 1-2 2015 Jun 181 191
214. E.M. Siegel, B.M. Riggs, A.L. Delmas, A. Koch, A. Hakam, and K.D. Brown Quantitative DNA methylation analysis of candidate genes in cervical cancer PLoS One 10 2015 e0122495
215. P. Brebi, L. Maldonado, M.G. Noordhuis, C. Ili, P. Leal, P. Garcia, M. Brait, J. Ribas, C. Michailidi, J. Perez, E. Soudry, O. Tapia, P. Guzman, S. Munoz, L. Van Neste, W. Van Criekinge, R. Irizarry, D. Sidransky, J.C. Roa, and R. Guerrero-Preston Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population Epigenetics 9 2013 308 317
216. J. Xu, L. Xu, B. Yang, L. Wang, X. Lin, and H. Tu Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer Int. J. Clin. Exp. Pathol. 8 2015 1674 1681
217. R.L. Huang, C.C. Chang, P.H. Su, Y.C. Chen, Y.P. Liao, H.C. Wang, Y.T. Yo, T.K. Chao, H.C. Huang, C.Y. Lin, T.Y. Chu, and H.C. Lai Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms PLoS One 7 2012 e41060
218. H.C. Lai, Y.W. Lin, R.L. Huang, M.T. Chung, H.C. Wang, Y.P. Liao, P.H. Su, Y.L. Liu, and M.H. Yu Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse Cancer 116 2010 4266 4274
219. C.C. Chang, R.L. Huang, Y.P. Liao, P.H. Su, Y.W. Hsu, H.C. Wang, C.Y. Tien, M.H. Yu, Y.W. Lin, and H.C. Lai Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm BMC Cancer 15 2015 418
220. S. Apostolidou, R. Hadwin, M. Burnell, A. Jones, D. Baff, N. Pyndiah, T. Mould, I.J. Jacobs, S. Beddows, G. Kocjan, and M. Widschwendter DNA methylation analysis in liquid-based cytology for cervical cancer screening Int. J. Cancer 125 2009 2995 3002
221. N. Vasiljevic, D. Scibior-Bentkowska, A.R. Brentnall, J. Cuzick, and A.T. Lorincz Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women Gynecol. Oncol. 132 2014 709 714
222. Y.L. Liou, Y. Zhang, Y. Liu, L. Cao, C.Z. Qin, T.L. Zhang, C.F. Chang, H.J. Wang, S.Y. Lin, T.Y. Chu, and H.H. Zhou Comparison of HPV genotyping and methylated ZNF582 as triage for women with equivocal liquid-based cytology results Clin. Epigenetics 7 2015 50
223. K. Louvanto, E.L. Franco, A.V. Ramanakumar, N. Vasiljevic, D. Scibior-Bentkowska, A. Koushik, J. Cuzick, F. Coutlee, and A.T. Lorincz Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16 Int. J. Cancer 136 2014 E638 E645
224. H.M. Muller, H. Fiegl, A. Widschwendter, and M. Widschwendter Prognostic DNA methylation marker in serum of cancer patients Ann. N. Y. Acad. Sci. 1022 2004 44 49
225. A. Widschwendter, H.M. Muller, M.M. Hubalek, A. Wiedemair, H. Fiegl, G. Goebel, E. Mueller-Holzner, C. Marth, and M. Widschwendter Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer Gynecol. Oncol. 93 2004 407 416
226. T. Jiang, L. Huang, S. Wang, and S. Zhang Clinical significance of serum Dkk-3 in patients with gynecological cancer J. Obstet. Gynaecol. Res. 36 2010 769 773